2
Clinical Trials associated with LIB-01Start Date25 Aug 2023 |
Sponsor / Collaborator- |
A Phase 1, Randomized, Double-blind, Parallel and Placebo-controlled Single and Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of LIB-01 in Healthy Participants.
The goal of this clinical trial is to learn about the safety, tolerability and pharmacokinetics of LIB-01 in healthy male participants. The main questions it aims to answer are:
How safe and tolerable is LIB-01 when given once or repeatedly at different dose levels.
What are the pharmacokinetic characteristics of LIB-01
Participants will receive LIB-01 and be followed up for safety and pharmacokinetics by:
Adverse events
ECG
Blood sampling for laboratory parameters and pharmacokinetic analysis
100 Clinical Results associated with LIB-01
100 Translational Medicine associated with LIB-01
100 Patents (Medical) associated with LIB-01
100 Deals associated with LIB-01